Sangeeta Shrotriya

Sangeeta Shrotriya currently serves as the Regional MSL Director at Summit Therapeutics, Inc., starting in December 2023, focusing on strategic planning and scientific research. Prior to this role, Sangeeta held multiple positions at Eisai US, including Director of MSL (interim) for lung cancer and Senior Oncology Medical Science Liaison/disease state lead, where responsibilities included medical strategy planning and KOL engagement. Sangeeta's experience also includes serving as a Medical Science Liaison in Oncology at Servier, lead clinical research at Terumo BCT where clinical studies were designed and executed, and managing clinical trials and R&D at LabCorp. Educational background includes a PhD in Molecular and Environmental Toxicology from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and completion of Leadership Essentials at Cornell University.